HSPB1 and glioblastoma: Ultimately, we observed a positive correlation between HSPB1 and the risk associated with the AS model, suggesting that heightened HSPB1 expression is intimately linked to an unfavorable prognosis in GBM patients, aligning with recent research conclusions [46, 47].